Orange Book product · Generic (ANDA)
BUPIVACAINE HYDROCHLORIDE
BUPIVACAINE HYDROCHLORIDE
At a glance
Feb 19, 2019
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Feb 19, 2019
7 yr 5 mo ago
Today
Pharmaceutical detail
Active ingredient
BUPIVACAINE HYDROCHLORIDE
Strength
0.5%
Dosage form
INJECTABLE
Route
INJECTION
TE code
Not listed
Application
ANDA 211096
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of BUPIVACAINE HYDROCHLORIDE
- 2020XARACOLLBrand (NDA)
NDA 209511 · INNOCOLL PHARMS
- 1992BUPIVACAINE HYDROCHLORIDE KITBrand (NDA)
NDA 019978 · HOSPIRA
- 1984MARCAINEBrand (NDA)
NDA 018692 · HOSPIRA
- —BUPIVACAINE HYDROCHLORIDEBrand (NDA)
NDA 018053 · HOSPIRA
- —MARCAINE HYDROCHLORIDEBrand (NDA)
NDA 016964 · HOSPIRA
- —SENSORCAINEBrand (NDA)
NDA 018304 · FRESENIUS KABI USA
- 2026BUPIVACAINE HYDROCHLORIDEGeneric (ANDA)
ANDA 220493 · ANTHEA PHARMA
- 2024BUPIVACAINE HYDROCHLORIDEGeneric (ANDA)
ANDA 217821 · ASPIRO
- 2023BUPIVACAINE HYDROCHLORIDEGeneric (ANDA)
ANDA 216040 · MEITHEAL
- 2023BUPIVACAINE HYDROCHLORIDEGeneric (ANDA)
ANDA 217792 · SOMERSET
- 2023BUPIVACAINE HYDROCHLORIDEGeneric (ANDA)
ANDA 216039 · MEITHEAL
- 2021BUPIVACAINE HYDROCHLORIDEGeneric (ANDA)
ANDA 205141 · HIKMA PHARMS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
